Position in ADCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$911,909
-$16,731 QoQ
Shares Held
243,176
-7.6% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. ADCT ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
99,106 | $58,767,875 | |
| 2 | VTRS |
Viatris Inc
|
3,882,541 | $52,453,128 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,602,543 | $48,199,096 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
959,257 | $46,188,223 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,788,811 | $45,175,103 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
1,982,724 | $44,809,561 | |
| 7 | LQDA |
Liquidia Corp
|
873,065 | $32,949,472 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
622,450 | $32,174,439 |
All Filings in ADCT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $911,909 | 243,176 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $928,640 | 263,071 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $895,365 | 284,243 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $833,329 | 263,712 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $120,875 | 26,921 | Shares | Defined | 2024-05-15 | |
| 2020-09-30 | $914,251 | 27,713 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||